Latest Insider Transactions at Cumberland Pharmaceuticals Inc (CPIX)
This section provides a real-time view of insider transactions for Cumberland Pharmaceuticals Inc (CPIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CUMBERLAND PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CUMBERLAND PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 27
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.94 P/Share
|
|
Apr 27
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.94 P/Share
|
|
Apr 27
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.94 P/Share
|
|
Apr 26
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.97 P/Share
|
|
Apr 26
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.97 P/Share
|
|
Apr 26
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.97 P/Share
|
|
Apr 26
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.97 P/Share
|
|
Apr 23
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.99 P/Share
|
|
Apr 23
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.99 P/Share
|
|
Apr 23
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.99 P/Share
|
|
Apr 23
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.99 P/Share
|
|
Apr 22
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.96 P/Share
|
|
Apr 22
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.96 P/Share
|
|
Apr 22
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.96 P/Share
|
|
Apr 22
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.96 P/Share
|
|
Apr 21
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.12%
|
$30
$2.97 P/Share
|
|
Apr 21
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$30
$2.97 P/Share
|
|
Apr 21
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$170
$2.97 P/Share
|
|
Apr 21
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$210
$2.97 P/Share
|
|
Apr 20
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.13%
|
$45
$3.02 P/Share
|
|
Apr 20
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$45
$3.02 P/Share
|
|
Apr 20
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$255
$3.02 P/Share
|
|
Apr 20
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$315
$3.02 P/Share
|
|
Apr 19
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.13%
|
$45
$3.04 P/Share
|
|
Apr 19
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$45
$3.04 P/Share
|
|
Apr 19
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$255
$3.04 P/Share
|
|
Apr 19
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$315
$3.04 P/Share
|
|
Apr 16
2021
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
15
+0.13%
|
$45
$3.03 P/Share
|
|
Apr 16
2021
|
A J Kazimi Chairman and CEO |
BUY
Open market or private purchase
|
Direct |
15
+0.0%
|
$45
$3.03 P/Share
|
|
Apr 16
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
85
+0.05%
|
$255
$3.03 P/Share
|
|
Apr 16
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
105
+0.07%
|
$315
$3.03 P/Share
|
|
Mar 17
2021
|
Michael Bonner Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,067
-5.26%
|
$3,201
$3.22 P/Share
|
|
Mar 17
2021
|
Leo Pavliv SVP and Chief Development Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,870
-1.68%
|
$8,610
$3.22 P/Share
|
|
Mar 17
2021
|
James L Herman VP and Chief Compliance Office |
SELL
Payment of exercise price or tax liability
|
Direct |
2,560
-5.38%
|
$7,680
$3.22 P/Share
|
|
Mar 17
2021
|
A J Kazimi Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+0.21%
|
$36,000
$3.22 P/Share
|
|
Mar 17
2021
|
A J Kazimi Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
37,350
-0.64%
|
$112,050
$3.22 P/Share
|
|
Mar 17
2021
|
Kenneth Krogulski Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.59%
|
$3,000
$3.22 P/Share
|
|
Mar 17
2021
|
Joseph C Galante |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+2.99%
|
$3,000
$3.22 P/Share
|
|
Mar 17
2021
|
Jonathan Griggs Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+6.33%
|
$3,000
$3.22 P/Share
|
|
Mar 17
2021
|
Joey A Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+4.83%
|
$15,000
$3.22 P/Share
|
|
Mar 17
2021
|
James Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+6.37%
|
$3,000
$3.22 P/Share
|
|
Mar 17
2021
|
Caroline Young Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+7.73%
|
$3,000
$3.22 P/Share
|
|
Mar 17
2021
|
Martin E Cearnal Sr VP/Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,945
-1.94%
|
$8,835
$3.22 P/Share
|